| answer text |
<p>We are introducing a new Accelerated Access Pathway, to streamline regulatory and
market access decisions, getting breakthrough products that we believe will be truly
transformative to patients more quickly. A new Accelerated Access Collaborative (AAC)
chaired by Sir Andrew Witty, will develop and own the Accelerated Access Pathway which
will be operational from April 2018. All products including medical technologies,
devices and diagnostics will be eligible for selection. In addition to the new Pathway,
the AAC will also make recommendations to the Government and its partners about opportunities
to further streamline existing routes to market.</p>
|
 |
